[1] Ross JS, Fletcher JA. The HER-2/neu oncogene in breast cancer:prognostic factor, predictive factor, and target for therapy [J].Oncologist, 1998, 3(4): 237-52. [2] Hynes NE, Stern DF. The biology of erbB-2/neu/Her-2 and its role in cancer[J]. Biochim Biophys Acta Rev Cancer, 1994, 1198 (2-3):165-84. [3] Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer:correlation of relapse and survival with amplification of the Her-2/neu oncogene[J]. Science, 1987, 235 (4785): 177-82. [4] Pietras RJ, Arboleda J, Reese DM, et al. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormoneindependent growth in human breast cancer cells [J]. Oncogene,1995, 10(12): 2435-46. [5] Ross JS, Fletcher JA. HER-2/neu (c-erb-B2) gene and protein in breast cancer[J]. Am J Clin Pathol, 1999, 112(1 Suppl 1): S53-67. [6] 张军一,麦国丰,郑航,等.乳腺癌HER2、EGFR表达与生存期的相关性[J].第一军医大学学报,2003,23(10):1090-2.Zhang JY, Mai GF, Zheng H, et al. Association between the survival time and high-expression of EGFR and HER-2 in breast cancer [J].J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2003, 23(10):1090-2. [7] 胡伟国,张保宁.Her2的研究进展与乳腺癌[J].肿瘤学杂志,2002,8(6):374-6. [8] McCann AH, Dervan PA, O’Regan M, et al. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer [J].Cancer Res, 1991, 51(12): 3296-303. [9] Read LD, Keith D Jr, Slamon DJ, et al. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines [J]. Cancer Res,1990, 50(13): 3947-51. [10] Lupu R, Lippman ME. The role of erbB2 signal transduction pathways in human breast cancer [J]. Breast Cancer Res Treat, 1993, 27(1-2): 83-93. [11] Barnes C J, Kumar R. Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets [J]. Cancer Metastasis Rev, 2003, 22(4): 301-7. |